Prediction of local recurrence in cervical cancer by a Cox model comprised of lymph node status, lymph-vascular space invasion, and intratumoral Th17 cell-infiltration

Medical Oncology

Volumn 31, Issue 1, 2014, Pages

  Yu, Qing ^a   Lou, Xiang Ming ^a   He, Yan ^b  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b Yiwu Maternity and Child Care Hospital   (China)

Author keywords

Cervical cancer; Local recurrence; Lymph node status; Lymph vascular space invasion; Th17 cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RADICAL HYSTERECTOMY; RECURRENCE RISK; REGULATORY T LYMPHOCYTE; TH17 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; UTERINE CERVIX CARCINOMA; COHORT ANALYSIS; CYTOLOGY; DISEASE FREE SURVIVAL; LYMPH NODE; METABOLISM; PATHOLOGY; PROGNOSIS; TUMOR INVASION; TUMOR RECURRENCE; UTERINE CERVICAL NEOPLASMS;

ADULT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TH17 CELLS; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 84888792525     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0795-1     Document Type: Article

References (27)

1. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342-50. (Pubitemid 37328947)
2. Singh N, Arif S. Histopathologic parameters of prognosis in cervical cancer - a review (translated from Eng). Int J Gynecol Cancer. 2004;14(5):741-50. (Pubitemid 39238156)
3. Kenter GG, et al. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma (translated from Eng). Acta Obstet Gynecol Scand. 2000;79(1):72-6. (Pubitemid 30045295)
4. Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation (translated from Eng). Gynecol Oncol. 2009;114(1):69-74.
5. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation (translated from Eng). Cell. 2011;144(5):646-74.
6. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer (translated from Eng). Cell. 2010;140(6):883-99.
7. Gao Q, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25(18):2586-93. (Pubitemid 47041232)
8. Sinicrope FA, et al. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma (translated from Eng). Gastroenterology. 2009;137(4):1270-9.
9. Salama P, et al. Tumor-infiltrating FOXP3 + T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol. 2009;27(2):186-92.
10. Kobayashi N, et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res. 2007;13(3):902-11. (Pubitemid 46340366)
11. Fu J, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology. 2007;132(7):2328-39. (Pubitemid 46890865)
12. Disis ML. Immune regulation of cancer (translated from Eng). J Clin Oncol. 2010;28(29):4531-8.
13. Sato E, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer (translated from Eng). Proc Natl Acad Sci USA. 2005;102(51):18538-43. (Pubitemid 43011261)
14. Chen KJ, et al. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection (translated from Eng). Med Oncol. 2011;29(3):1817-26.
15. Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization (translated from Eng). Clin Cancer Res. 2004;10(21):7252-9. (Pubitemid 39487712)
16. Pages F, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer (translated from eng). J Clin Oncol. 2009;27(35):5944-51.
17. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome (translated from eng). Nat Rev Cancer. 2012;12(4):298-306.
18. Zhang JP, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients (translated from eng). J Hepatol. 2009;50(5):980-9.
19. Tosolini M, et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer (translated from eng). Cancer Res. 2011;71(4):1263-71.
20. Langowski JL, et al. IL-23 promotes tumour incidence and growth. Nature. 2006;442(7101):461-5. (Pubitemid 44264796)
21. Wang L, et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway (translated from eng). J Exp Med. 2009;206(7):1457-64.
22. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137-48. (Pubitemid 39094044)
23. Martin-Orozco N, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity. 2009;31(5):787-98.
24. Lin SZ, et al. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Cancer Prev Res (Phila). 2013;6(6):594-602.
25. Diederichsen AC, Hjelmborg J, Christensen PB, Zeuthen J, Fenger C. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells (translated from Eng). Cancer Immunol Immunother. 2003;52(7):423-8. (Pubitemid 36831363)
26. Mlecnik B, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction (translated from Eng). J Clin Oncol. 2011;29(6):610-8.
27. Galon J, Fridman WH, Pages F. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective (translated from Eng). Cancer Res. 2007;67(5):1883-6. (Pubitemid 46424201)